Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MZL R/R*** > Treatment > CN. I. BTK Inhibitor
CN. I. BTK Inhibitor's subsections
(*) CN Approval Date: 2023. 04.20
Company
Generic Name
Patent>CN Patent Numbers
Patent>SG Patent Numbers
Patent>USA Patent Numbers
TM
CN. I. BTK Inhibitor's products
This section has no products